Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
David O. Taylor, MD, is a board-certified cardiologist in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine in the Sydell and Arnold Miller Heart & Vascular Institute at Cleveland Clinic and a Professor at the Cleveland Clinic Lerner College of medicine of Case Western Reserve University. He is the Director of the Heart Failure and Transplantation Fellowship.
Dr. Taylor earned his medical degree at the University of New Mexico School of Medicine, Albuquerque. He served a residency in internal medicine at the Medical College of Virginia followed by fellowships in cardiology and heart failure and cardiac transplantation.
Prior to joining Cleveland Clinic in 2001, Dr. Taylor served 10 years at the University of Utah where he was Medical Director of the Cardiac Transplant Program. He was a Professor of Medicine in the Division of Cardiology at the University of Utah Medical Center, receiving five Outstanding Teaching Awards during his tenure there.
Dr. Taylor was elected President of the International Society for Heart and Lung Transplantation for 2011-12 and is currently on the Board of Directors of the International Society for Heart and Lung Transplantation for 2011-2013 (previously 2000 to 2003). Prior to this he has served as the Associate Director for Heart Transplantation for the International Society Transplantation Registry. He serves on the editorial board and as a reviewer for many leading journals in his specialty, including Journal of Heart and Lung Transplantation, American Heart Journal and Journal of the American College of Cardiology and is Associate Editor of the prestigious American Journal of Transplantation. He also serves as an abstract grader at national and international scientific meetings and has chaired numerous scientific symposia and plenary sessions.
He has been principal investigator or co-investigator on numerous studies related to cardiac transplantation and treatment of congestive heart failure. Dr. Taylor is widely published in leading peer-reviewed medical journals on topics in his specialty interests and is the author of multiple chapters in medical textbooks on cardiovascular-related subjects. A frequent lecturer at symposia and conferences worldwide, Dr. Taylor in 1996 was Co-Chair of the Medical Affairs Committee for the United States Transplant Olympic Games.
Dr. Taylor is board-certified in internal medicine and cardiovascular diseases. His special interests include congestive heart failure, cardiac transplantation, mechanical circulatory support.
Cardiomyopathy, cardiac tumors, heart failure, heart transplantation, ventricular assist device, myocardial biopsy, cardiac catheterization
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 4/29/2015, Dr. Taylor has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.